Jazz (JAZZ) Director Patrick Kennedy Sells Shares for Tax Withholding

What Happened
Patrick Kennedy, a director of Jazz Pharmaceuticals plc, disposed of 1,855 shares on August 31, 2026 to satisfy tax withholding obligations tied to the vesting of previously granted restricted stock units (RSUs). The sales consisted of 15 shares at $244.06 ($3,661) and 1,840 shares at $241.39 ($444,158), for a combined cash value of approximately $447,819. These were disposals (not purchases) and reflect routine tax-withholding rather than an open-market sell decision.

Key Details

• Transaction date: August 31, 2026; Form 4 filed September 2, 2026.
• Individual trades: 15 shares @ $244.06 = $3,661; 1,840 shares @ $241.39 = $444,158.
• Total shares disposed: 1,855; total value ≈ $447,819.
• Transaction code: F — payment of exercise price or tax liability (footnote: shares sold to satisfy tax obligations from RSU vesting).
• Shares owned after the transactions: not reported in the provided filing excerpt.
• Filing timeliness: Form filed 2026-09-02 for an 08-31 transaction (within the typical 2-business-day window).

Context
These sales were tax-withholding disposals tied to vested RSUs (common practice). Such transactions are routine and do not necessarily signal a change in an insider’s view of the company.